The Protective Effects of Metformin and Vitamin C and Their Co-Administration in Bleomycin-Induced Pulmonary Fibrosis in Mice

Bleomycin, an antibacterial antibiotic, is used in chemotherapy and is effective against various forms of human carcinomas. However, its use is limited due to its tendency to cause pulmonary fibrosis. Oxidative stress and excessive expression of TGF beta occur in pulmonary fibrosis, leading to cellu...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohammad Ebrahim Abbaszadeh, Mohammad Rafi Khezri, Morteza Ghasemnejad-Berenji
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:Advances in Pharmacological and Pharmaceutical Sciences
Online Access:http://dx.doi.org/10.1155/adpp/5227142
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849738404530487296
author Mohammad Ebrahim Abbaszadeh
Mohammad Rafi Khezri
Morteza Ghasemnejad-Berenji
author_facet Mohammad Ebrahim Abbaszadeh
Mohammad Rafi Khezri
Morteza Ghasemnejad-Berenji
author_sort Mohammad Ebrahim Abbaszadeh
collection DOAJ
description Bleomycin, an antibacterial antibiotic, is used in chemotherapy and is effective against various forms of human carcinomas. However, its use is limited due to its tendency to cause pulmonary fibrosis. Oxidative stress and excessive expression of TGF beta occur in pulmonary fibrosis, leading to cellular death, inflammation, and additional damage to lung tissue. Metformin has the ability to reduce oxidative stress and lower the level of TGF beta by activating AMPK. Additionally, ascorbic acid possesses potent antioxidant characteristics. Consequently, we decided to investigate the effects of these two medications on pulmonary fibrosis and compare with methyl prednisolone. Thirty-six adult mice were categorized into 6 distinct groups: Control, bleomycin (bleo), bleo + methyl prednisolone, bleo + metformin, bleo + ascorbic acid, bleo + metformin + ascorbic acid. Pulmonary fibrosis was induced by the administration of bleomycin in all groups, except for the control group. Subsequently, medications were administered for a duration of 14 days. Ultimately, the mice were sacrificed and lung tissues were obtained for biochemical and histological examination. As shown by biochemical and histological analysis, all treatment groups showed a decrease in oxidative stress factors, inflammation, and lung tissue fibrosis; however, the effects of administering metformin and ascorbic acid together were noticeable. Our study found that administering metformin and ascorbic acid over a period of 14 days, either alone or in combination, may contribute to the repair of pulmonary fibrosis. However, our data indicate that the combined therapy of these drugs provided a better result.
format Article
id doaj-art-f5f4a111ce3d4836b8d7d27bdcedec22
institution DOAJ
issn 2633-4690
language English
publishDate 2025-01-01
publisher Wiley
record_format Article
series Advances in Pharmacological and Pharmaceutical Sciences
spelling doaj-art-f5f4a111ce3d4836b8d7d27bdcedec222025-08-20T03:06:36ZengWileyAdvances in Pharmacological and Pharmaceutical Sciences2633-46902025-01-01202510.1155/adpp/5227142The Protective Effects of Metformin and Vitamin C and Their Co-Administration in Bleomycin-Induced Pulmonary Fibrosis in MiceMohammad Ebrahim Abbaszadeh0Mohammad Rafi Khezri1Morteza Ghasemnejad-Berenji2Department of Anatomical SciencesUrmia University of Medical SciencesDepartment of Pharmacology and ToxicologyBleomycin, an antibacterial antibiotic, is used in chemotherapy and is effective against various forms of human carcinomas. However, its use is limited due to its tendency to cause pulmonary fibrosis. Oxidative stress and excessive expression of TGF beta occur in pulmonary fibrosis, leading to cellular death, inflammation, and additional damage to lung tissue. Metformin has the ability to reduce oxidative stress and lower the level of TGF beta by activating AMPK. Additionally, ascorbic acid possesses potent antioxidant characteristics. Consequently, we decided to investigate the effects of these two medications on pulmonary fibrosis and compare with methyl prednisolone. Thirty-six adult mice were categorized into 6 distinct groups: Control, bleomycin (bleo), bleo + methyl prednisolone, bleo + metformin, bleo + ascorbic acid, bleo + metformin + ascorbic acid. Pulmonary fibrosis was induced by the administration of bleomycin in all groups, except for the control group. Subsequently, medications were administered for a duration of 14 days. Ultimately, the mice were sacrificed and lung tissues were obtained for biochemical and histological examination. As shown by biochemical and histological analysis, all treatment groups showed a decrease in oxidative stress factors, inflammation, and lung tissue fibrosis; however, the effects of administering metformin and ascorbic acid together were noticeable. Our study found that administering metformin and ascorbic acid over a period of 14 days, either alone or in combination, may contribute to the repair of pulmonary fibrosis. However, our data indicate that the combined therapy of these drugs provided a better result.http://dx.doi.org/10.1155/adpp/5227142
spellingShingle Mohammad Ebrahim Abbaszadeh
Mohammad Rafi Khezri
Morteza Ghasemnejad-Berenji
The Protective Effects of Metformin and Vitamin C and Their Co-Administration in Bleomycin-Induced Pulmonary Fibrosis in Mice
Advances in Pharmacological and Pharmaceutical Sciences
title The Protective Effects of Metformin and Vitamin C and Their Co-Administration in Bleomycin-Induced Pulmonary Fibrosis in Mice
title_full The Protective Effects of Metformin and Vitamin C and Their Co-Administration in Bleomycin-Induced Pulmonary Fibrosis in Mice
title_fullStr The Protective Effects of Metformin and Vitamin C and Their Co-Administration in Bleomycin-Induced Pulmonary Fibrosis in Mice
title_full_unstemmed The Protective Effects of Metformin and Vitamin C and Their Co-Administration in Bleomycin-Induced Pulmonary Fibrosis in Mice
title_short The Protective Effects of Metformin and Vitamin C and Their Co-Administration in Bleomycin-Induced Pulmonary Fibrosis in Mice
title_sort protective effects of metformin and vitamin c and their co administration in bleomycin induced pulmonary fibrosis in mice
url http://dx.doi.org/10.1155/adpp/5227142
work_keys_str_mv AT mohammadebrahimabbaszadeh theprotectiveeffectsofmetforminandvitamincandtheircoadministrationinbleomycininducedpulmonaryfibrosisinmice
AT mohammadrafikhezri theprotectiveeffectsofmetforminandvitamincandtheircoadministrationinbleomycininducedpulmonaryfibrosisinmice
AT mortezaghasemnejadberenji theprotectiveeffectsofmetforminandvitamincandtheircoadministrationinbleomycininducedpulmonaryfibrosisinmice
AT mohammadebrahimabbaszadeh protectiveeffectsofmetforminandvitamincandtheircoadministrationinbleomycininducedpulmonaryfibrosisinmice
AT mohammadrafikhezri protectiveeffectsofmetforminandvitamincandtheircoadministrationinbleomycininducedpulmonaryfibrosisinmice
AT mortezaghasemnejadberenji protectiveeffectsofmetforminandvitamincandtheircoadministrationinbleomycininducedpulmonaryfibrosisinmice